Cart
0

Electrophysiology Market by Product (EP Ablation Catheters, EP Laboratory Devices, EP Diagnostic Catheters, Access Devices), Indication (Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia, Wolff-Parkinson-White Syndrome) - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

Get 20% Free Customization In This Report
LI_16452
Pages: 120
Sep 2016 | 2696 Views
 
Author's : Garima Chandra
Tables: 46
Charts: 85
 

Electrophysiology Market Overview:

The global electrophysiology market size was $3,420 million in 2015, and is expected to reach $8,271 million by 2022, while growing at a CAGR of 13.4% from 2016 to 2022. Electrophysiology (EP) is the branch of cardiology that deals with the diagnosis and treatment of heart rhythm disorders.

Get more information on this report : Request Sample Pages

The EP study helps in the assessment of electrical impulses of the heart and to evaluate abnormal heartbeats. The significant advancement in the EP technologies have enhanced the ability to target the areas of the heart perpetuating that leads to atrial fibrillation (AF). The growing development has improved the diagnosis and treatment of other cardiac arrhythmias as well that include atrial flutter, Wolff-Parkinson-White Syndrome (WPW), atrioventricular nodal reentry tachycardia (AVNRT), and others. Based on product type, the electrophysiology industry is segmented into EP ablation catheters, EP laboratory devices, EP diagnostic catheters, and access devices. The EP ablation catheters segment holds a remarkable portion in the global electrophysiology market share, and is expected to grow at the fastest rate during the study period. This is attributed by the growing preference of catheter ablation for the treatment of cardiac arrhythmias and increased adoption by the physicians.

Segment Review:

EP ablation is a minimally invasive procedure, which employs catheters to destroy faulty electrical pathways from heart. The device is useful in removal of the abnormal heart tissues that cause irregular heart rhythms. Radiofrequency and cryoablation types are the most widely used EP ablation catheters, and are expected to register significant market capture with pertinent advancements in the technology. In addition, the number of ablation procedures performed for the treatment of atrial fibrillation is expected to increase substantially in the foresee future. Catheter ablation is a low-risk process with high success rates, making it the most preferred modality for the treatment of cardiac arrhythmias. The treatment of cardiac arrhythmias, especially atrial fibrillation, by cardiac ablation is the potential target area for investment by the key players in this segment.

The atrial fibrillation application accounted for the majority market share in 2015. The cryoablation segment is poised to grow at a CAGR of 15.1% from 2016 to 2022. This growth is attributed to the elimination of disadvantages related with radiofrequency ablation, such as burns of RF, that disrupts the endothelium, tamponades, thromboembolic strokes, and atrial-oesophageal fistula. Moreover, cryoablation catheter ablation and laser ablation is a low-risk process with high success rates, making it a most preferred treatment modality for cardiac arrhythmias.

Asia Pacific Electrophysiology Market Scenario

The Asia-Pacific region includes China, Japan, India, Australia, South Korea, and other countries in the Asia-Pacific Rim. The region offers lucrative opportunities in the segment, and is anticipated to be the fastest growing market during the forecast period. Asia-Pacific is a densely-populated region, with India and China being the most populated countries. Emerging economies, such as India and China, provide attractive growth opportunities for electrophysiological device manufactures. The growth is supplemented by the increase in demand for advanced electrophysiology devices, an improvement of healthcare reforms, high prevalence of cardiac arrhythmias, and increased focus of key players for developing technologically advanced cost-effective electrophysiology devices in this region. However, the unfavorable reimbursement scenario for electrophysiology devices, low awareness among physicians and patients about different EP devices, and high cost of these devices are likely to impede the market growth in these countries. In Japan, the atrial fibrillation rate among geriatric population is 2-3%. With the rise in ageing population, it is estimated that atrial fibrillation will affect about one million people by 2050, thereby driving the electrophysiology devices market growth. 

The electrophysiology ablation catheters market is chiefly segmented on the basis of energy sources used for ablating cardiac cells and tissues such as cryoablation EP catheters, radiofrequency ablation catheters, microwave, and laser ablation system. Navigational advanced mapping accessories also perform the EP procedure. Among these, radiofrequency ablation catheters market is further categorized into conventional RF ablation catheters and irrigated-tip RF ablation catheters. RF ablation catheters is the potential target areas for investment by the key players in the electrophysiology market. RF ablation catheters is the highest revenue-generating segment in the EP ablation catheters market owing to the advancements in RF ablation devices that positively impact the growth of the EP market. For example, irrigated-tip RF ablation catheters, which lowers the likelihood of char or thrombus formation and aids the creation of larger lesions. These technologically advanced RF ablation devices offers treatment that is more effective with potentially lower risks and lead to the high market growth.

Competitors in the market have launched technologically advanced electrophysiology devices for gaining a competitive edge. For instance, the top players of the market, such as Biosense Webster, St Jude Medical, Boston Scientific Corporation and Medtronic, hold impressive product portfolio in varied range. For instance, St Jude: FlexAbility Ablation Catheter, Sensor Enabled, and EnSite Precision Cardiac Mapping System; Medtronic: 4 mm RF Conductr (Multi-Curve) Series Ablation Catheters, 5 mm RF Conductr (Multi-Curve) Series Ablation Catheters, RF Contactr (Dual-Curve) Series Ablation Catheters, and BLAZER PRIME Temperature Ablation Catheter; and Boston Scientific Corporation: IntellaTip MiFi XP Catheter, Blazer II HTD temperature ablation catheter, and Chilli II cooled ablation catheter. Therefore, this increased pace of technological advancements in the field of electrophysiology and growth in demand of EP devices for the treatment of cardiac arrhythmias is poised to boost the EP market growth at a double-digit rate during the forecast period.  

St. Jude Medical, Inc., Biosense Webster, Inc. (a Johnson & Johnson Company), Boston Scientific Corporation, GE Healthcare (a division of General Electric Company.), Siemens AG, Medtronic plc, Philips Healthcare (a division of Koninklijke Philips N.V.), Biotronik SE & Co.KG, Microport Scientific Corporation, and Abbott Laboratories are the key players that operate in this market.

ELECTROPHYSIOLOGY MARKET KEY BENEFITS 

  • The study provides an in-depth analysis of the global electrophysiology industry with current trends and future estimations to elucidate the imminent investment pockets in the market.
  • The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of the market, by product, helps in understanding the various types of devices used for the treatment of atrial fibrillation and other related cardiac arrhythmias.
  • Competitive intelligence highlights the business practices followed by leading market players across various geographical regions
  • Porter’s Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.

Electrophysiology Market Key Segments

By Product

  • EP Ablation Catheters 
    • Cryoablation EP Catheters
    • Radiofrequency Ablation Catheters
      • Irrigated-tip Radiofrequency Ablation Catheters
      • Conventional Radiofrequency Ablation Catheters
    • Microwave Ablation Systems
    • Laser Ablation Systems
    • Navigational Advanced Mapping Accessories
  • EP Laboratory Devices
    • EP X-Ray Systems
    • 3D Mapping Systems
    • EP Recording Systems
    • EP Remote Steering Systems
    • Others
  • EP Diagnostic Catheters
    • Conventional EP Diagnostic Catheters
      • Steerable Diagnostic Catheters
      • Fixed Diagnostic Catheters
    • Advanced EP Diagnostic Catheters
    • Ultrasound EP Diagnostic Catheters
  • Access Devices
  • Others

By Indication

  • Atrial Fibrillation (AF)
  • Atrial Flutter
  • Wolff-Parkinson-White Syndrome (WPW) 
  • Atrioventricular Nodal Reentry Tachycardia (AVNRT) 
  • Others

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil 
    • Argentina
    • Egypt
    • Israel
    • South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key market benefits
1.3 Key market segments:
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threats of new entrants
3.3.4 Threats of substitutes
3.3.5 High intensity of rivalry

3.4 Market share analysis, 2015
3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Technological advancements in EP Devices
3.5.1.2 Growing incidence of AF due to increasing baby booming generation
3.5.1.3 Unmet medical needs with upcoming treartment modifictions
3.5.1.4 Increasing preference of EP catheter ablation for cardiac arrhythmia treatment

3.5.2 Restraints

3.5.2.1 High cost of the EP Device
3.5.2.2 Dearth of skilled electrophysiologists
3.5.2.3 Preference to pharmaceutical interventions (drugs) over EP treatment devices

3.5.3 Opportunities

3.5.3.1 Lucrative opportunities in emerging economies
3.5.3.2 Rising awareness regarding the EP technologies

Chapter: 4 WORLD ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2014-2022, ($MILLION)

4.1 Overview

4.1.1 Market size and forecast

4.2 EP ablation catheters

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Cryoablation EP catheters

4.2.4.1 Market size and forecast

4.2.5 Radiofrequency (RF) ablation catheters

4.2.5.1 Market size and forecast
4.2.5.2 Conventional RF ablation catheters

4.2.5.2.1 MARKET SIZE AND FORECAST

4.2.5.3 Irrigated-tip RF ablation catheters

4.2.5.3.1 MARKET SIZE AND FORECAST

4.2.6 Microwave ablation (MWA) systems

4.2.6.1 Market size and forecast

4.2.7 Laser ablation systems

4.2.7.1 Market size and forecast

4.2.8 Navigational advanced mapping accessories

4.2.8.1 Market size and forecast

4.3 EP laboratory devices

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 3D mapping systems

4.3.4.1 Market size and forecast

4.3.5 EP recording systems

4.3.5.1 Market size and forecast

4.3.6 EP X-Ray systems

4.3.6.1 Market size and forecast

4.3.7 EP remote steering systems

4.3.7.1 Market size and forecast

4.3.8 Others

4.3.8.1 Market size and forecast

4.4 Electrophysiology diagnostic catheters

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Conventional EP diagnostic catheters

4.4.4.1 Market size and forecast
4.4.4.2 Fixed diagnostic catheters

4.4.4.2.1 MARKET SIZE AND FORECAST

4.4.4.3 Steerable diagnostic catheters

4.4.4.3.1 MARKET SIZE AND FORECAST

4.4.5 Advanced EP diagnostic catheters

4.4.5.1 Market size and forecast

4.4.6 Ultrasound EP diagnostic catheters

4.4.6.1 Market size and forecast

4.5 Access devices

4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast

4.6 Others

4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast

Chapter: 5 WORLD ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2014-2022

5.1 Overview

5.1.1 Market size and forecast

5.2 Atrial Fibrillation

5.2.1 Market size and forecast

5.3 Atrial Flutter

5.3.1 Market size and forecast

5.4 Atrioventricular Nodal Reentrant Tachycardia (AVNRT)

5.4.1 Market size and forecast

5.5 Wolff-Parkinson-White Syndrome (WPW)

5.5.1 Market size and forecast

5.6 Others

5.6.1 Market size and forecast

Chapter: 6 WORLD ELECTROPHYSIOLOGY MARKET, BY GEOGRAPHY, 2014-2022

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.2.3.1 U.S. Market size and forecast
6.2.3.2 Canada Market size and forecast
6.2.3.3 Mexico Market size and forecast

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.3.3.1 Germany Market size and forecast
6.3.3.2 France Market size and forecast
6.3.3.3 U.K. Market size and forecast
6.3.3.4 Italy Market size and forecast
6.3.3.5 Rest of Europe Market size and forecast

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.4.3.1 India Market size and forecast
6.4.3.2 China Market size and forecast
6.4.3.3 Japan Market size and forecast
6.4.3.4 Australia Market size and forecast
6.4.3.5 Rest of Asia-Pacific Market size and forecast

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

6.5.3.1 Brazil Market size and forecast
6.5.3.2 Argentina Market size and forecast
6.5.3.3 Egypt Market size and forecast
6.5.3.4 IsraelMarket size and forecast
6.5.3.5 South Africa Market size and forecast
6.5.3.6 Rest of LAMEA Market size and forecast

Chapter: 7 COMPANY PROFILES

7.1 Abbott Laboratories

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Business performance
7.1.5 Key strategic moves and developments

7.2 Johnson & Johnson

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Business performance
7.2.5 Key strategic moves and developments

7.3 Microport Scientific Corporation

7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Business performance
7.3.5 Key strategic moves and developments

7.4 Boston Scientific Corporation

7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves and developments

7.5 St. Jude Medical, Inc.

7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Business performance
7.5.5 Key strategic moves and developments

7.6 Medtronic plc

7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Business performance
7.6.5 Key strategic moves and developments

7.7 Biotronik SE & Co. KG

7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Key strategic moves and developments

7.8 Koninklijke Philips N.V.

7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Business performance
7.8.5 Key strategic moves and developments

7.9 General Electric Co.

7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments overview
7.9.4 Business performance
7.9.5 Key strategic moves and developments

7.10 Siemens AG

7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Financial performance
7.10.5 Key strategic moves and developments

List of Figures

FIG. 1 WORLD EP MARKET, BY PRODUCT, 2015 VS 2022, ($MILLION)
FIG. 2 MARKET SEGMENTATION FOR EP MARKETS
FIG. 3 TOP INVESTMENT POCKETS IN WORLD ELECTROPHYSIOLOGY MARKET
FIG. 4 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20132016)
FIG. 5 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 6 TYPES OF STRATEGIES DISTRIBUTION
FIG. 7 TOP COMPANIES AND THEIR STRATEGIES
FIG. 8 DETAILED STRUCTURE OF COMPANIES: TYPE OF STRATEGIES (20132016)
FIG. 9 DETAILED STRUCTURE OF COMPANIES: NATURE OF STRATEGIES (20132016)
FIG. 10 PORTERS FIVE FORCES ANALYSIS
FIG. 11 MARKET SHARE ANALYSIS, 2015
FIG. 12 WORLD EP CRYOABLATION CATHETER MARKET, 20142022 ($MILLION)
FIG. 13 WORLD CONVENTIONAL RF ABLATION CATHETERS MARKET, 20142022 ($MILLION)
FIG. 14 WORLD IRRIGATED ABLATION CATHETERS MARKET, 20142022 ($MILLION)
FIG. 15 WORLD MICROWAVE ABLATION SYSTEM MARKET, 20142022 ($MILLION)
FIG. 16 WORLD LASER ABLATION SYSTEM MARKET, 20142022 ($MILLION)
FIG. 17 WORLD NAVIGATIONAL ADVANCED MAPPING ACCESSORIES MARKET, 20142022 ($MILLION)
FIG. 18 WORLD 3D MAPPING SYSTEMS MARKET, 20142022 ($MILLION)
FIG. 19 WORLD EP RECORDING SYSTEM MARKET, 20142022 ($MILLION)
FIG. 20 WORLD EP X-RAY IMAGING SYSTEMS MARKET, 20142022 ($MILLION)
FIG. 21 WORLD EP REMOTE STEERING SYSTEMS MARKET, 20142022 ($MILLION)
FIG. 22 WORLD CONVENTIONAL EP DIAGNOSTIC CATHETER MARKET, 20142022 ($MILLION)
FIG. 23 WORLD FIXED DIAGNOSTIC CATHETERS MARKET, 20142022 ($MILLION)
FIG. 24 WORLD STEERABLE DIAGNOSTIC CATHETERS MARKET, 20142022 ($MILLION)
FIG. 25 WORLD ADVANCED DIAGNOSTIC CATHETERS MARKET, 20142022 ($MILLION)
FIG. 26 WORLD ULTRASOUND EP DIAGNOSTIC CATHETER MARKET, 20142022 ($MILLION)
FIG. 28 AF CASES IN U.S., 20102050 (MILLION)
FIG. 29 U.S. EP MARKET, (20142022) ($MILLION)
FIG. 30 CANADA EP MARKET, (20142022) ($MILLION)
FIG. 31 MEXICO EP MARKET, (20142022) ($MILLION)
FIG. 32 GERMANY EP MARKET, (20142022) ($MILLION)
FIG. 33 FRANCE EP MARKET, (20142022) ($MILLION)
FIG. 34 U.K. EP MARKET, (20142022) ($MILLION)
FIG. 35 ITALY EP MARKET, (2014-2022) ($MILLION)
FIG. 36 REST OF EUROPE EP MARKET, (2014-2022) ($MILLION)
FIG. 37 AGE SPECIFIC WEIGHTED PREVALENCE RATE OF AF IN CHINA, 2015 (%)
FIG. 38 INDIA EP MARKET, (20142022) ($MILLION)
FIG. 39 CHINA EP MARKET, (20142022) ($MILLION)
FIG. 40 JAPAN EP MARKET, (20142022) ($MILLION)
FIG. 41 AUSTRALIA EP MARKET, (20142022) ($MILLION)
FIG. 42 REST OF ASIA-PACIFIC EP MARKET, (20142022) ($MILLION)
FIG. 43 PREVELANCE RATE OF ATRIAL FIBRILLATION (AF) ACCORDING TO AGE AND SEX IN BRAZIL, 2015 (%)
FIG. 44 BRAZIL EP MARKET, (20142022) ($MILLION)
FIG. 45 ARGENTINA EP MARKET, (20142022) ($MILLION)
FIG. 46 AFRICA EP MARKET, (20142022) ($MILLION)
FIG. 47 ISRAEL EP MARKET, (20142022) ($MILLION)
FIG. 48 SOUTH AFRICA EP MARKET, (20142022) ($MILLION)
FIG. 49 REST OF LAMEA EP MARKET, (20142022) ($MILLION)
FIG. 54 J&J: REVENUE, 2013-2015 ($MILLION)
FIG. 55 J&J: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 56 J&J: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 57 J&J: STRATEGY SHARE, 20142015 (%)
FIG. 58 MICROPORT: REVENUE, 20132015, ($MILLION)
FIG. 59 MICROPORT: REVENUE BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 60 MICROPORT: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 61 MICROPORT: STRATEGY SHARE, 20132015 (%)
FIG. 62 BOSTON SCIENTIFIC: REVENUE, 20132015, ($MILLION)
FIG. 63 BOSTON SCIENTIFIC: REVENUE BY BUSINESS SEGMENT, 2015 (%)
FIG. 64 BOSTON SCIENTIFIC: RHYTHM MANAGEMENT REVENUE BY SUB-SEGMENT, 2015 (%)
FIG. 65 BOSTON SCIENTIFIC: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 66 BOSTON SCIENTIFIC: STRATEGY SHARE, 2013-2016 (%)
FIG. 67 ST. JUDE MEDICAL: REVENUE, 20132015 ($MILLION)
FIG. 68 ST. JUDE MEDICAL: REVENUE BY PRODUCT CATEGORY, 2015 (%)
FIG. 69 ST. JUDE MEDICAL: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 70 ST. JUDE MEDICAL: STRATEGY SHARE, 20142016 (%)
FIG. 71 MEDTRONIC: REVENUE, 20142016 ($MILLION)
FIG. 72 MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)
FIG. 73 MEDTRONIC: CARDIAC AND VASCULAR GROUP NET SALES, BY SUB-SEGMENT, 2016 (%)
FIG. 74 MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIG. 75 FIG. 20 MEDTRONIC: STRATEGY SHARE, 20142016 (%)
FIG. 76 PHILIPS: REVENUE, 20132015, ($MILLION)
FIG. 77 PHILIPS: REVENUE BY SEGMENT, 2015 (%)
FIG. 78 PHILIPS: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 79 PHILLIPS: STRATEGY SHARE, 20152016 (%)
FIG. 80 GE: REVENUE, 20132015 ($MILLION)
FIG. 81 GE: REVENUE BY SEGMENT 2015 (%)
FIG. 82 GE: REVENUE BY GEOGRAPHY 2015 (%)
FIG. 83 SEIMENS: REVENUE, 2013-2015, ($MILLION)
FIG. 84 SEIMENS: REVENUE BY SEGMENT, 2015 (%)
FIG. 85 SEIMENS: REVENUE BY GEOGRAPHY, 2015 (%)

List of Tables

TABLE 1 COMPETITIVE LANDSCAPE IN EP MARKET
TABLE 2 WORLD EP MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 3 WORLD EP ABLATION CATHETERS MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 4 WORLD EP ABLATION CATHETERS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 5 WORLD EP LABORATORY DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 6 WORLD EP LABORATORY DEVICES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 7 WORLD EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 8 WORLD EP DIAGNOSTIC CATHETERS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 9 WORLD ACCESS DEVICES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 10 WORLD OTHER PRODUCT TYPE MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 11 WORLD EP MARKET, BY INDICATION, 20142022 ($MILLION)
TABLE 12 WORLD EP MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 16 WORLD WPW SYNDROME MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 17 WORLD OTHER INDICATION MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 18 WORLD EP MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 19 NORTH AMERICA: EP MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 20 NORTH AMERICA: EP MARKET, BY TYPE, (2014-2022) ($MILLION)
TABLE 21 EUROPE: EP MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 22 EUROPE: EP MARKET, BY TYPE, (2014-2022) ($MILLION)
TABLE 23 ASIA-PACIFIC: EP MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 24 ASIA-PACIFIC: EP MARKET, BY TYPE, (2014-2022) ($MILLION)
TABLE 25 LAMEA: EP MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 26 LAMEA: EP MARKET, BY TYPE, (2014-2022) ($MILLION)
TABLE 27 ABBOTTCOMPANY SNAPSHOT
TABLE 28 ABBOTTOPERATING SEGMENTS
TABLE 29 J&JCOMPANY SNAPSHOT
TABLE 30 J&JOPERATING SEGMENTS
TABLE 31 MICROPORTCOMPANY SNAPSHOT
TABLE 32 MICROPORTOPERATING SEGMENTS
TABLE 33 BOSTON SCIENTIFICCOMPANY SNAPSHOT
TABLE 34 BOSTON SCIENTIFICOPERATING SEGMENTS
TABLE 35 ST. JUDE MEDICALCOMPANY SNAPSHOT
TABLE 36 ST. JUDE MEDICALOPERATING SEGMENTS
TABLE 37 MEDTRONICCOMPANY SNAPSHOT
TABLE 38 MEDTRONICOPERATING SEGMENTS
TABLE 39 BIOTRONIKCOMPANY SNAPSHOT
TABLE 40 BIOTRONIKOPERATING SEGMENTS
TABLE 41 PHILIPSCOMPANY SNAPSHOT
TABLE 42 PHILIPSOPERATING SEGMENTS
TABLE 43 GECOMPANY SNAPSHOT
TABLE 44 GEOPERATING SEGMENTS
TABLE 45 SIEMENSCOMPANY SNAPSHOT
TABLE 46 SIEMENSOPERATING SEGMENTS

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Electrophysiology Market- Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

  • Online Only
  • $4176
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo